Nitrendipine, a Calcium-Entry Blocker: Renal and Humoral Effects in Human Arterial Hypertension

Roberto Pedrinelli, Fetnat M. Fouad, Robert C. Tarazi, Emmanuel L. Bravo, Stephen C Textor

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

• Thirteen patients with hypertension and normal renal function received nitrendipine, a calcium entry blocker. Nitrendipine did not modify renal blood flow (RBF) or glomerular filtration rate (GFR), decreased mean arterial pressure (MAP) and total peripheral resistance, and did not significantly change cardiac output. Individual RBF changes did not correlate with MAP or cardiac output modifications. Mean arterial pressure changes were inversely correlated with basal renin levels and directly associated with age. Plasma catecholamines and plasma renin activity increased, but plasma aldosterone and plasma volume did not change significantly. However, the greater decrements of MAP tended to be associated with the greater increases in plasma volume. Data show that long-term calcium entry blockade by nitrendipine does not modify RBF or GFR despite the decreased renal perfusion pressure. Further, nitrendipine may be more effective in older patients and the presence of low renin.

Original languageEnglish (US)
Pages (from-to)62-65
Number of pages4
JournalArchives of Internal Medicine
Volume146
Issue number1
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Nitrendipine
Renal Circulation
Arterial Pressure
Renin
Hypertension
Calcium
Kidney
Plasma Volume
Glomerular Filtration Rate
Cardiac Output
Renal Hypertension
Aldosterone
Vascular Resistance
Catecholamines
Perfusion
Pressure

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Nitrendipine, a Calcium-Entry Blocker : Renal and Humoral Effects in Human Arterial Hypertension. / Pedrinelli, Roberto; Fouad, Fetnat M.; Tarazi, Robert C.; Bravo, Emmanuel L.; Textor, Stephen C.

In: Archives of Internal Medicine, Vol. 146, No. 1, 1986, p. 62-65.

Research output: Contribution to journalArticle

Pedrinelli, Roberto ; Fouad, Fetnat M. ; Tarazi, Robert C. ; Bravo, Emmanuel L. ; Textor, Stephen C. / Nitrendipine, a Calcium-Entry Blocker : Renal and Humoral Effects in Human Arterial Hypertension. In: Archives of Internal Medicine. 1986 ; Vol. 146, No. 1. pp. 62-65.
@article{b3ce4bb4c95341e78b6889aa4588f095,
title = "Nitrendipine, a Calcium-Entry Blocker: Renal and Humoral Effects in Human Arterial Hypertension",
abstract = "• Thirteen patients with hypertension and normal renal function received nitrendipine, a calcium entry blocker. Nitrendipine did not modify renal blood flow (RBF) or glomerular filtration rate (GFR), decreased mean arterial pressure (MAP) and total peripheral resistance, and did not significantly change cardiac output. Individual RBF changes did not correlate with MAP or cardiac output modifications. Mean arterial pressure changes were inversely correlated with basal renin levels and directly associated with age. Plasma catecholamines and plasma renin activity increased, but plasma aldosterone and plasma volume did not change significantly. However, the greater decrements of MAP tended to be associated with the greater increases in plasma volume. Data show that long-term calcium entry blockade by nitrendipine does not modify RBF or GFR despite the decreased renal perfusion pressure. Further, nitrendipine may be more effective in older patients and the presence of low renin.",
author = "Roberto Pedrinelli and Fouad, {Fetnat M.} and Tarazi, {Robert C.} and Bravo, {Emmanuel L.} and Textor, {Stephen C}",
year = "1986",
doi = "10.1001/archinte.1986.00360130072010",
language = "English (US)",
volume = "146",
pages = "62--65",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Nitrendipine, a Calcium-Entry Blocker

T2 - Renal and Humoral Effects in Human Arterial Hypertension

AU - Pedrinelli, Roberto

AU - Fouad, Fetnat M.

AU - Tarazi, Robert C.

AU - Bravo, Emmanuel L.

AU - Textor, Stephen C

PY - 1986

Y1 - 1986

N2 - • Thirteen patients with hypertension and normal renal function received nitrendipine, a calcium entry blocker. Nitrendipine did not modify renal blood flow (RBF) or glomerular filtration rate (GFR), decreased mean arterial pressure (MAP) and total peripheral resistance, and did not significantly change cardiac output. Individual RBF changes did not correlate with MAP or cardiac output modifications. Mean arterial pressure changes were inversely correlated with basal renin levels and directly associated with age. Plasma catecholamines and plasma renin activity increased, but plasma aldosterone and plasma volume did not change significantly. However, the greater decrements of MAP tended to be associated with the greater increases in plasma volume. Data show that long-term calcium entry blockade by nitrendipine does not modify RBF or GFR despite the decreased renal perfusion pressure. Further, nitrendipine may be more effective in older patients and the presence of low renin.

AB - • Thirteen patients with hypertension and normal renal function received nitrendipine, a calcium entry blocker. Nitrendipine did not modify renal blood flow (RBF) or glomerular filtration rate (GFR), decreased mean arterial pressure (MAP) and total peripheral resistance, and did not significantly change cardiac output. Individual RBF changes did not correlate with MAP or cardiac output modifications. Mean arterial pressure changes were inversely correlated with basal renin levels and directly associated with age. Plasma catecholamines and plasma renin activity increased, but plasma aldosterone and plasma volume did not change significantly. However, the greater decrements of MAP tended to be associated with the greater increases in plasma volume. Data show that long-term calcium entry blockade by nitrendipine does not modify RBF or GFR despite the decreased renal perfusion pressure. Further, nitrendipine may be more effective in older patients and the presence of low renin.

UR - http://www.scopus.com/inward/record.url?scp=84941816335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941816335&partnerID=8YFLogxK

U2 - 10.1001/archinte.1986.00360130072010

DO - 10.1001/archinte.1986.00360130072010

M3 - Article

C2 - 2935106

AN - SCOPUS:84941816335

VL - 146

SP - 62

EP - 65

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 1

ER -